Scottsdale, AZ – Aug 21, 2024 – NeoLight, a pioneering medical device company and Arizona State University (ASU) spinoff, is proud to announce a major milestone: its life-changing neonatal care equipment has positively impacted over 200,000 babies in 99 countries worldwide since its market introduction. As a high-growth company, NeoLight continues to rapidly expand its global reach and innovate new solutions to address critical needs in neonatal care.
"We're thrilled to have passed this milestone, and we're just getting started," said Vivek Kopparthi, NeoLight Co-founder and CEO. "By investing in the health and well-being of babies, we're creating a lasting impact that will benefit them for the rest of their lives."
NeoLight's comprehensive portfolio of products addresses critical needs in neonatal care, advancing the standard of care for the smallest patients.
"[Our son Jude] spent three weeks in the NICU, and the other phototherapy lights weren't strong enough for him. He would have had to stay there a long time, but thanks to Skylife, our little baby Jude was able to come home. It’s been wonderful having him home," said Malia, a mother whose son was treated on the Skylife Neonatal Phototherapy System.
This milestone demonstrates NeoLight's continued growth and commitment to innovation in neonatal care. Partnering with NeoLight offers a unique opportunity to make a meaningful impact on the lives of babies and families while driving growth and innovation in the neonatal care sector. With a focus on developing cutting-edge solutions for the smallest patients, NeoLight is poised for continued success and expansion.
"At NeoLight, we're passionate about being true partners with clinicians, providing innovative solutions that enhance patient care," said MaryBeth Smith, NeoLight Chief Commercial Officer. "Our global impact is a testament to the trust clinicians have placed in us. We're proud to have made a difference in the lives of 200,000 babies worldwide, and we're committed to continuing our mission to advance neonatal care."
As NeoLight continues to grow exponentially, we remain dedicated to being true partners with clinicians, advancing the standard of care, and transforming the lives of babies and families worldwide. Our commitment to innovation and excellence has enabled us to achieve this remarkable milestone, and we're eager to continue pushing the boundaries of what's possible in neonatal care. Join us in our mission to shape the future of healthcare and create a brighter tomorrow for generations to come.
###
NeoLight is a medical device company that develops empathy driven, best-in-class technologies for treating preventable conditions in the newborn care market. Empathy driven solutions are a framework that has the doctor-nurse-mother-infant ecosystem at the center. It fosters the emotional connection that happens, thereby providing not just treatment but also providing care. Driving neonatal care beyond the traditional hospital setting, NeoLight is also creating a robust home market to treat neonatal conditions in the home. To learn more, visit www.theneolight.com and follow us on Twitter and LinkedIn.
